Study | Patients (n) | Tumor size (cm) | Histological subtype (%) | FNCLCC grade (%) | Tumour status (%) | Margin status (%) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | V | T | V | T | V | T | V | T | V | T | V | T |
Tan 201629 | 67 | 608 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Ikoma 201731 | 36 | 136 | NA | NA | Lei, 100 | Lei, 100 | NA | NA | NA | NA | R0/R1 100 | R0/R1 100 |
Blair 201832 | 32 | 96 | 11.3 | 10.2 | Lip, 19; Lei, 81 | Lip, 19; Lei, 81 | G1, 6; G2,31; G3, 63 | G1, 12; G2, 28; G3, 60 | P, 84; R, 16 | P, 78; R, 22 | R0/R1 93; R2 9 | R0/R1 88; R2 12 |
Spolverato 202110 | 24 | 401 | 25 | 25 | Lip, 100 | Lip, 100 | G1, 25; G2/G3, 75 | G1, 33; G2/G3, 67 | P, 100 | P, 100 | R0/R1 96; R2 4 | R0/R1 98; R2 2 |